ACT runs Incognito-like ads for anonymous HIV testing.

TORONTO, June 21, 2019 /CNW/ – ACT (formerly Aids Committee of Toronto) uses an unconventional approach to create awareness around anonymous HIV testing. 51% of people living with HIV in Canada are gay or bisexual men. But, over 20% of gay and bisexual men don’t get tested as often as they should for many reasons, including fear of being judged or the test showing up on their medical record. Yet, many don’t know that getting HIV tested can be completely anonymous.

ACT wanted to let them know about anonymous HIV testing but needed to be discreet. The ads can be found in the most anonymous place on the Internet: Incognito mode. Google Chrome’s private browsing mode helps ensure others won’t know what we’re doing or where we’ve gone online. While you could be searching for your spouse’s birthday gift in Incognito mode, it’s more often used for pornography or hookup and dating sites. We wanted to hit our target right when they might go Incognito online for sexual discretion and assure them that they can have that same discretion and anonymity when they get HIV tested.

Unfortunately, Incognito mode is anonymous – so how do we advertise to people in Incognito mode when we can’t tell when users are in it? We display the ads on sites that our target demographic might visit in Incognito mode such as Squirt, Pornhub, YouPorn, Spankwire, XHamster, etc. Then we simply asked the question, “Are you Incognito online?” The ads will drive them to a landing page listing all anonymous (or incognito) HIV testing clinics in Toronto.

What if they’ve never heard of Incognito? Our ads empower them with the knowledge that there is an anonymous and safe way to get educated and informed about HIV online.

About ACT (formerly Aids Committee of Toronto):

Founded in 1983, ACT works to reduce new HIV infections in Toronto and promotes the independence, dignity, health and well-being of people living with HIV and AIDS and those at increased risk of HIV.

SOURCE ACT (formerly Aids Committee of Toronto)

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2019/21/c6304.html

Staff

Recent Posts

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

16 hours ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

16 hours ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

16 hours ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

16 hours ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

16 hours ago

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

SAN JOSE, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…

16 hours ago